3308-02-9

Basic information

• Product Name: 3-HYDROXY-2-PHENYLPYRIDINE
• Synonyms: 2-phenyl-3-pyridino;2-Phenyl-3-hydroxypyridine;3-Pyridinol, 2-phenyl-;4-N-(2-bromophenyl)pyrido[4,3-d]pyrimidine-4,7-diamine;3-HYDROXY-2-PHENYLPYRIDINE;2-PHENYL-3-PYRIDINOL;2-PHENYL-PYRIDIN-3-OL
• CAS NO: 3308-02-9
• Molecular Formula: C₁₁H₉NO
• Molecular Weight: 171.2
• Product Categories: Pyridines, Pyrimidines, Purines and Pteredines;pharmacetical
• Mol File: 3308-02-9.mol
• Article Data: 18

Chemical Properties

• Melting Point: 205 °C
• Boiling Point: 378.1°Cat760mmHg
• Flash Point: 182.5°C
• Appearance: /
• Density: 1.169g/cm³
• Vapor Pressure: 2.95E-06mmHg at 25°C
• Refractive Index: 1.611
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 8.23±0.10(Predicted)
• CAS DataBase Reference: 3-HYDROXY-2-PHENYLPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-HYDROXY-2-PHENYLPYRIDINE(3308-02-9)
• EPA Substance Registry System: 3-HYDROXY-2-PHENYLPYRIDINE(3308-02-9)

Safety Data

• Hazardous Substances Data: 3308-02-9(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Tetrahedron, 48, p. 8117, 1992 DOI: 10.1016/S0040-4020(01)80481-6

InChI:InChI=1/C11H9NO/c13-10-7-4-8-12-11(10)9-5-2-1-3-6-9/h1-8,13H

Upstream product

• 6636-78-8 2-chloro-3-hydroxypyridine 
• 98-80-6 phenylboronic acid 
• 6602-32-0 2-bromo-pyridin-3-ol 
• 497-19-8 sodium carbonate 
• 1000414-79-8 (2S)-1-benzyl-2-phenyl-1,6-dihydropyridin-3(2H)-one 
• 1008-89-5 2-phenylpyridine 
• 109-00-2 3-HYDROXYPYRIDINE 
• 40263-57-8 2-iodo-3-hydroxypyridine 
• 1431753-26-2 C₁₉H₁₉NO₃ 
• 1431753-25-1 C₁₈H₁₉NO₃S 
• 1431753-23-9 C₁₇H₂₃NO₄ 
• 1431753-22-8 C₂₀H₂₁NO₄ 
• 1431753-21-7 C₁₉H₂₁NO₄S 
• 917823-87-1 (R)-Allylamino-phenyl-acetic acid methyl ester 

Downstream Products

• 117645-01-9 Phosphoric acid mono-(2-phenyl-pyridin-3-yl) ester 
• 117645-00-8 C₁₇H₂₆NO₄PSi₂ 
• 31838-55-8 6-iodo-2-phenylpyridin-3-ol 
• 148701-78-4 tert-butyl 3-oxo-2-phenylpiperidine-1-carboxylate 
• 479030-35-8 1-benzyl-2-phenylpiperidin-3-one 
• 117644-98-1 Phosphoric acid diethyl ester 2-phenyl-pyridin-3-yl ester 
• 108881-06-7 1-acetonyl-3-hydroxy-2-phenyl-pyridinium; bromide 

Relevant articles and documents

1-Phenyl-8-azabicyclo[3.2.1]octane ethers: A novel series of neurokinin (NK1) antagonists

1-Phenyl-8-azabicyclo[3.2.1]octane ethers are NK1 receptor antagonists. Substitution at the 6-exo-position led to high affinity NK 1 antagonists with a prolonged duration of action in vivo. Incorporation of an α-methyl substituent in

(PYRIDIN-2-YL)AMINE DERIVATIVES AS TGF-BETA R1 (ALK5) INHIBITORS FOR THE TREATMENT OF CANCER

The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder associated with ΤGFβR1 activity, such as a cancer or fibrosis. The invention provides compounds of Formula (I) and Formula (II) as further described herein having an acidic moiety that enhances tissue specificity for targeted tissues and organs. The invention includes pharmaceutical compositions, pharmaceutical combinations, and methods of use of these compounds for treating conditions including cancer or fibrosis.

INHIBITORS OF THE KYNURENINE PATHWAY

The present application provides novel inhibitors of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase, metabolites thereof, and phannaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. A therapeutically effective amount of one or more of the compounds of formula (I) is useful in treating diseases resulting from dysregulation of the kynurenine pathway. Compounds of formula (I) act by inhibiting the enzymatic activity or expression of indoleamine 2,3-dioxygenase-1 and/or indoleamine 2,3-dioxygenase-2 and/or tryptophan 2,3-dioxygenase.